TabsDetailsBasic DetailsDate Posted: Wednesday, October 21, 2020Status: CompleteMedical Product: 3-dose rotavirus vaccination, RotaTeqHealth Outcome(s): adherenceDescription: This request identified oral dose administrations of Pentavalent Rotavirus Vaccine (RV5) among infants with a birth date in the Sentinel Distributed Database (SDD) and assessed adherence measures per guidelines set by the Food and Drug Administration (FDA) and the Advisory Committee on Immunization Practices (ACIP). The study included infants with birth dates from January 1, 2014 to December 31, 2017. We distributed this request on September 30, 2019 to seven Data Partners contributing to the SDD. Read More Deliverables (1)Sentinel Modular Program Report: Adherence to Pentavalent Rotavirus Vaccine (RV5) 3-Dose ScheduleAdditional InformationAdditional DetailsFDA Center: CBERTime Period: January 1, 2014 to December 31, 2018Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: InfantsData Sources: Sentinel Distributed Database (SDD)Related Links: Adherence to Monovalent Rotavirus Vaccine (RV1) 2-Dose Schedule